• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Pediatrics

Transgender adults who received puberty suppression report lower suicidal ideation

byMichael DinhandCordelia Ross
January 23, 2020
in Pediatrics, Psychiatry
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In multivariable analysis based on survey data, transgender adults who wanted and received pubertal suppression therapy had lower odds of lifetime suicidal ideation, compared with transgender adults who wanted but did not receive the therapy.

2. Overall, very few (2.5%) of the respondents who had wanted pubertal suppression received it. Those who were younger, had greater family support of gender identity, and higher total household income were more likely to have received pubertal suppression if they had wanted it.

Evidence Rating Level: 3 (Average)

Study Rundown: Previous studies have demonstrated that transgender youth suffer from elevated risk of suicidality and internalizing psychopathology. Gender-affirming interventions, including “puberty blocking” treatments based on gonadotropin-releasing hormone analogues, have been developed for transgender adolescents, but few studies have examined the association between these treatments and mental health. In this cross-sectional study, researchers used national survey data of transgender adults aged 18 to 36 years from the 2015 US Transgender Survey to study the relationship between pubertal suppression and adult mental health outcomes, including measures of suicidality and substance use. After adjusting for socioeconomic traits, individuals who had received pubertal suppression had significantly lower odds of lifetime suicidal ideation when compared with individuals who had wanted but did not receive the intervention.

This study was limited by its cross-sectional design, and reverse causation cannot be ruled out. Nonetheless, the study is strengthened by its large, nationally-representative data set. For physicians, these findings highlight the importance of making pubertal suppression therapy available to transgender adolescents who want it.

Click to read the study, published today in Pediatrics

Relevant reading: Young Adult Psychological Outcome After Puberty Suppression and Gender Reassignment

RELATED REPORTS

Vitamin D supplementation in children increases serum levels but may not impact growth

Study examines early re-transition rate for young transgender children

Suicide prevention videos may help improve suicidal ideation and help seeking in adolescents

In-Depth [cross-sectional study]: Researchers used survey data from the 2015 US Transgender Survey from the National Center for Transgender Equality. Participants included 20 619 transgender adults aged 18 to 36 years recruited through community outreach. Surveys were conducted online and anonymously and collected data on socioeconomic traits, past desire for and use of puberty blocking hormones, and adult mental health outcomes, including past-month severe psychologic distress, lifetime illicit drug use, and past-year and lifetime suicidal ideation, plan, and attempts. Multivariable logistic regression was used to examine associations between pubertal suppression and adult mental health outcomes.

Of the survey respondents included in the sample, 16.9% reported that they have ever wanted pubertal suppression, while only 89 (2.5%) of these respondents reported having received this treatment. After adjusting for socioeconomic traits, including family support, sexual orientation, education level, and total household income, individuals who received pubertal suppression had decreased odds of lifetime suicidal ideation (adjusted odds ratio [aOR]: 0.3; 95% confidence interval [CI]: 0.2-0.6), when compared with those who wanted pubertal suppression but did not receive it. There were no significant differences between individuals who did and did not receive pubertal suppression in mental health and substance use in multivariable analyses.

Image: PD

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: pubertypuberty suppressionsuicidal ideationtransgendertransgender health
Previous Post

Pediatric discharge transition survey demonstrates congruence with other validated tools

Next Post

Teprotumumab may significantly improve outcomes in patients with active thyroid eye disease

RelatedReports

Adolescent mothers in protective care more likely to have their children placed in care
Chronic Disease

Vitamin D supplementation in children increases serum levels but may not impact growth

December 16, 2022
AAP recommends disaster preparedness measures for children
Endocrinology

Study examines early re-transition rate for young transgender children

July 14, 2022
Parents often unaware of adolescents’ suicidal thoughts
Pediatrics

Suicide prevention videos may help improve suicidal ideation and help seeking in adolescents

December 14, 2021
Participation in sports and exercise linked to lower opioid use
Wellness

Transgender veterans may be more likely to use amphetamine, cocaine, and cannabis than cisgender veterans

October 22, 2021
Next Post
Teprotumumab may significantly improve outcomes in patients with active thyroid eye disease

Teprotumumab may significantly improve outcomes in patients with active thyroid eye disease

Elagolix with add-back hormone therapy effective in reducing fibroid-associated menstrual bleeding

Elagolix with add-back hormone therapy effective in reducing fibroid-associated menstrual bleeding

Concussion or mild traumatic brain injury linked with increased risk of suicide

Suicidal attempts and death rates in the United States from 2007 to 2014

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Chronic obstructive pulmonary disease associated with worse postoperative outcomes
  • Empagliflozin use is associated with slower progression of chronic kidney disease
  • Diagnostic tool may help identify cerebral palsy regardless of encephalopathy features
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options